Table 2 Comparison of clinical and pathological parameters according to body mass index
Parameter | ≤ Normal | Overweight | Obese | p-value |
|---|---|---|---|---|
Number | 63 | 73 | 86 | |
Age (years) | 68.57 ± 6.06 | 68.07 ± 6.85 | 67.07 ± 5.76 | 0.321 |
IOM (mm2/cm2) | 10.84 ± 2.18 | 11.13 ± 2.02 | 11.59 ± 2.37 | 0.115 |
BMI (kg/m2) | 21.11 ± 1.45 | 24.06 ± 0.51 | 27.25 ± 1.79 | < 0.001 |
Pre-op PSA (ng/mL) | 13.97 ± 17.97 | 11.01 ± 10.93 | 10.40 ± 10.57 | 0.237 |
Prostate volume (cc) | 32.54 ± 12.95 | 33.01 ± 14.39 | 37.54 ± 14.42 | 0.062 |
Type of operation | 0.291 | |||
RRP | 48 (76.2) | 58 (79.5) | 57 (66.3) | |
LRP | 0 (0.0) | 0 (0.0) | 1 (1.2) | |
RARP | 15 (23.8) | 15 (20.5) | 28 (32.6) | |
Gleason score | 0.165 | |||
≤ 6 | 14 (22.2) | 20 (27.4) | 25 (29.1) | |
7 | 43 (68.3) | 49 (67.1) | 53 (61.6) | |
8 | 5 (7.9) | 1 (1.4) | 2 (2.3) | |
9 | 1 (1.6) | 3 (4.1) | 6 (7.0) | |
T-stage | 0.220 | |||
T2a | 7 (11.1) | 14 (19.2) | 7 (8.1) | |
T2b | 7 (11.1) | 13 (17.8) | 18 (20.9) | |
T2c | 37 (58.7) | 37 (50.7) | 45 (52.3) | |
T3a | 5 (7.9) | 5 (6.8) | 11 (12.8) | |
T3b | 7 (11.1) | 4 (5.5) | 5 (5.8) | |
N-stage | 0.524 | |||
0 | 62 (98.4) | 72 (98.6) | 86 (100) | |
1 | 1 (1.6) | 1 (1.4) | 0 (0.0) | |
cM stage | 0.282 | |||
0 | 62 (98.4) | 73 (100) | 86 (100.0) | |
1 | 1 (1.6) | 0 (0.0) | 0 (0.0) | |
BCR | 0.521 | |||
0 | 46 (73.0) | 59 (80.8) | 68 (79.1) | |
1 | 17 (27.0) | 14 (19.2) | 18 (20.9) |